Aplastic anaemia is a rare and serious blood disorder in which bone marrow fails to produce enough blood cells. It commonly occurs when the immune system attacks bone marrow stem cells. Certain infections, inherited disorders, medical treatments, and exposure to harmful chemicals may increase the risk of developing the condition. The condition can cause infections, bleeding and fatigue. Manipal Hospitals offers comprehensive evaluation and advanced management for aplastic anaemia.
Get in touch with our representatives for help!
Request a CallbackAplastic anaemia symptoms usually develop gradually over weeks or months, though in some cases it appears suddenly. Common signs include persistent fatigue, frequent infections, easy bruising or bleeding, shortness of breath, and pale skin. Some patients may also experience dizziness, headache, or fever due to reduced blood cell production.
Aplastic anaemia diagnosis begins with a detailed clinical assessment and review of symptoms such as fatigue, infections and bleeding. Doctors perform blood tests, including a complete blood count and reticulocyte count, to evaluate cell levels. A peripheral blood smear and bone marrow aspiration with biopsy help confirm reduced bone marrow cell production. Manipal Hospitals provides a comprehensive diagnostic evaluation for aplastic anaemia.
Aplastic anaemia treatment options depend on severity and underlying cause. Management may include immunosuppressant medicines, blood transfusions, antibiotics for infections and allogeneic stem cell transplantation. Care focuses on restoring blood cell production and preventing complications. Manipal Hospitals offers comprehensive treatment and supportive care for aplastic anaemia.
At Manipal Hospitals, treatment begins with a detailed consultation and careful review of medical history. Specialists assess symptoms such as fatigue, infections and bleeding concerns. A thorough physical examination is followed by blood tests, including complete blood count and reticulocyte count. If required, peripheral smear analysis and bone marrow aspiration with biopsy help confirm the diagnosis. The team evaluates disease severity and identifies possible underlying causes before developing an individualised treatment plan.
Once confirmed, aplastic anaemia management may include immunosuppressant therapy, blood transfusions or antibiotics to control infections. In suitable cases, allogeneic stem cell transplantation is discussed after careful evaluation. Doctors provide clear explanations about procedures, benefits and potential side effects. Psychological support and counselling are offered when needed to help patients cope with long-term treatment. Scheduled follow-up visits help monitor blood counts and treatment response. Ongoing support ensures timely adjustments to therapy and promotes long-term health stability. Patients also receive guidance on lifestyle precautions and infection prevention measures as part of continued care.
Aplastic anaemia is not a cancer. It is a bone marrow failure disorder in which the marrow does not produce enough blood cells. However, in rare cases, it may increase the risk of developing certain blood cancers over time.
Early aplastic anaemia symptoms often include persistent fatigue, frequent infections, easy bruising, shortness of breath and pale skin. Symptoms may develop gradually and can resemble common illnesses, which sometimes delay timely medical evaluation.
Aplastic anaemia causes commonly include autoimmune reactions where the immune system attacks bone marrow stem cells. Viral infections, inherited bone marrow disorders, certain medications, chemotherapy, radiation and exposure to toxic chemicals may also contribute.
Aplastic anaemia diagnosis involves blood tests such as complete blood count and reticulocyte count. Doctors may perform a peripheral blood smear and bone marrow aspiration with biopsy to confirm reduced bone marrow cell production and rule out other blood disorders.
Stem cell transplantation is not required for every individual. Aplastic anaemia treatment depends on severity, age, and overall health. Some patients respond well to immunosuppressant medicines and supportive therapies without requiring transplantation.
Visit the Global site for International patient services